Molecular Pharmacology of Medicinal Plants
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 108
Special Issue Editor
Interests: clinical phytopharmacology; phytopharmacology; polyphytotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is well known that medicinal plants have various therapeutic values that can be used for the treatment of many ailments, resulting from their content in bioactive phytochemicals with several biological properties. Many cardiovascular drugs such as reserpine, digoxin, and deslanoside are isolated and developed from plants. Natural products have always been a major source for drug development in cancer therapy. A considerable portion of anticancer drugs currently used in the clinic are of natural origin, e.g., Vinca alkaloids, taxanes, and others. The same observation was made with diabetes medicines such as metformin, among others. Some medicinal plants have demonstrated their action on the immune system, but more research is still needed to learn more about the different properties and mechanisms involved in acting on the immune system. This Special Issue aims to provide an overview of the latest progress made in the field of medicinal plant research and the molecular and clinical phytopharmacology of plant extracts from cellular and molecular pharmacology to demonstrate the full potential of medicinal plants. Original research papers and review articles focused on these different areas are welcome.
Dr. Bruno Eto
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- medicinal plants
- drug development
- molecular pharmacology
- clinical phytopharmacology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
